NexgenRx Inc
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquarte… Read more
NexgenRx Inc (NEGXF) - Total Liabilities
Latest total liabilities as of June 2025: $27.59 Million USD
Based on the latest financial reports, NexgenRx Inc (NEGXF) has total liabilities worth $27.59 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NexgenRx Inc - Total Liabilities Trend (2005–2024)
This chart illustrates how NexgenRx Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
NexgenRx Inc Competitors by Total Liabilities
The table below lists competitors of NexgenRx Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Olidata S.p.A.
F:OL40
|
Germany | €74.15 Million |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM
|
USA | $11.14 Million |
|
Fun Yours Technology Co Ltd
TWO:6482
|
Taiwan | NT$122.61 Million |
|
Max Power Mining Corp.
PINK:MAXXF
|
USA | $150.26K |
|
MBL Infrastructure Limited
NSE:MBLINFRA
|
India | ₹20.29 Billion |
|
Sabre Gold Mines Corp
OTCQB:SGLDF
|
USA | $19.14 Million |
|
WASHINGTON POST -B- - Dusseldorf Stock Exchang
DU:WPOB
|
Germany | €3.35 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down NexgenRx Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NexgenRx Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NexgenRx Inc (2005–2024)
The table below shows the annual total liabilities of NexgenRx Inc from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $22.84 Million | +1.60% |
| 2023-12-31 | $22.48 Million | +34.24% |
| 2022-12-31 | $16.75 Million | -15.73% |
| 2021-12-31 | $19.87 Million | +0.53% |
| 2020-12-31 | $19.77 Million | -0.57% |
| 2019-12-31 | $19.88 Million | +69.02% |
| 2018-12-31 | $11.76 Million | +91.25% |
| 2017-12-31 | $6.15 Million | +11.05% |
| 2016-12-31 | $5.54 Million | +15.78% |
| 2015-12-31 | $4.78 Million | -30.29% |
| 2014-12-31 | $6.86 Million | +399.74% |
| 2013-12-31 | $1.37 Million | -9.92% |
| 2012-12-31 | $1.52 Million | -15.15% |
| 2011-12-31 | $1.80 Million | -2.00% |
| 2010-12-31 | $1.83 Million | -46.79% |
| 2009-12-31 | $3.45 Million | -44.49% |
| 2008-12-31 | $6.21 Million | +3.50% |
| 2007-12-31 | $6.00 Million | +16.68% |
| 2006-12-31 | $5.14 Million | -49.08% |
| 2005-12-31 | $10.09 Million | -- |